Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Paumgartner

Showing results (81-90 of 315) with videos related to

Pageof 32
Sort By:
Wiener Klinische Wochenschrift|June 26, 1970
[Experimental and clinical results of a new blood pressure increasing substance (2,5-dimethoxyphenyl-2-glycinamidoethanol-1-hydrochloride)]G Paumgartner, D Pokorny, G Grabner
Hepatology (Baltimore, Md.)|June 1, 1989
Bile acid metabolism in human hyperthyroidismJ Pauletzki, F Stellaard, G Paumgartner
Scandinavian Journal of Gastroenterology|January 1, 1976
Inhibition of bile formation by high doses of taurocholate in the perfused rat liverR Herz, G Paumgartner, R Preisig
FEBS Letters|August 18, 1986
Muscarinic M2-receptors enhance polyphosphoinositol release in rat gastric mucosal cellsA Pfeiffer, G Paumgartner, A Herz
Experientia|October 15, 1975
Prostaglandin-induced choleresis in the ratB Lauterburg, G Paumgartner, R Preisig
Experientia|April 15, 1982
Studies on the in vitro binding of D-penicillamine to cholestyramineH Allgayer, W Kruis, G Paumgartner
Journal of Hepatology|March 1, 1990
Assessment of hepatic function. Comparison of caffeine clearance in serum and saliva during the day and at nightA Wahlländer, S Mohr, G Paumgartner
Pediatrics|May 1, 1977
Determination of bile acid concentration in human amniotic fluid for prenatal diagnosis of intestinal obstructionG Délèze, D Sidiropoulos, G Paumgartner
Schweizerische Medizinische Wochenschrift|April 16, 1977
[Does cholestyramine impair the bioavailability of prednisolone?]V Audétat, G Paumgartner, J Bircher
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1994
Ursodeoxycholic acid treatment of cholesterol gallstone diseaseG Paumgartner, J Pauletzki, M Sackmann
Pageof 32

Showing results (81-90 of 315) with videos related to

Sort By:
Pageof 32
Wiener Klinische Wochenschrift|June 26, 1970
[Experimental and clinical results of a new blood pressure increasing substance (2,5-dimethoxyphenyl-2-glycinamidoethanol-1-hydrochloride)]G Paumgartner, D Pokorny, G Grabner
Hepatology (Baltimore, Md.)|June 1, 1989
Bile acid metabolism in human hyperthyroidismJ Pauletzki, F Stellaard, G Paumgartner
Scandinavian Journal of Gastroenterology|January 1, 1976
Inhibition of bile formation by high doses of taurocholate in the perfused rat liverR Herz, G Paumgartner, R Preisig
FEBS Letters|August 18, 1986
Muscarinic M2-receptors enhance polyphosphoinositol release in rat gastric mucosal cellsA Pfeiffer, G Paumgartner, A Herz
Experientia|October 15, 1975
Prostaglandin-induced choleresis in the ratB Lauterburg, G Paumgartner, R Preisig
Experientia|April 15, 1982
Studies on the in vitro binding of D-penicillamine to cholestyramineH Allgayer, W Kruis, G Paumgartner
Journal of Hepatology|March 1, 1990
Assessment of hepatic function. Comparison of caffeine clearance in serum and saliva during the day and at nightA Wahlländer, S Mohr, G Paumgartner
Pediatrics|May 1, 1977
Determination of bile acid concentration in human amniotic fluid for prenatal diagnosis of intestinal obstructionG Délèze, D Sidiropoulos, G Paumgartner
Schweizerische Medizinische Wochenschrift|April 16, 1977
[Does cholestyramine impair the bioavailability of prednisolone?]V Audétat, G Paumgartner, J Bircher
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1994
Ursodeoxycholic acid treatment of cholesterol gallstone diseaseG Paumgartner, J Pauletzki, M Sackmann
Pageof 32